-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8

Benzinga·09/16/2026 12:47:57
Listen to the news
Barclays analyst Glen Santangelo upgrades Alvotech (NASDAQ:ALVO) from Underweight to Overweight and raises the price target from $4 to $8.